Tag:#EMMAC Life Sciences

UK Regulators Under-Fire As Only One More Supplier And 20 Products Added To Novel Food List

THE latest iteration of the UK Food Standards Agency list of Validated Novel Food CBD applications has been published with just one more supplier...

Euro Cannabis Leader Alfredo Pascual To Join UK Investor With £12m-Plus To Deploy

UK investment fund Fast Forward Innovations has added Alfredo Pascual - one of Europe’s leading cannabis industry figures - to its team, as it...

Curaleaf’s Recreational Cannabis Stores May Become A Feature Of Europe’s High Streets

EMMAC CEO Antonio Costanzo believes its purchase by US and global leader Curaleaf is a signal to Europe’s politicians that it is time to...

Largest US Cannabis Retailer Buys Europe’s Largest Medical Cannabis Independent

SPECULATION EMMAC Life Sciences would be the next to float on the London Stock Exchange has been brought to a swift conclusion - with...

Chinese CBD Market In The Sights Of Yooma After £6m EMMAC Deal

UK cannabis business EMMAC Life Sciences Group has sold its Yooma Wellness business for over $8m with the emerging Chinese wellness market in the...

Six Companies Chosen to Supply Products – Free Of Charge – To France’s First Medical Cannabis Trial

SIX companies have seen their products selected for use in the French medical cannabis trial for 3,000 patients which is set to begin with...

Markets: UK CBD Firm’s Stock Price Up 1000% In 2020, Tilray & Aphria, EMMAC et al…

THIS time last year cannabis businesses were in the doldrums so the picture currently being viewed would have seemed a mirage back then. Stock prices...

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Must read